Cipla Ltd. is an Indian pharmaceutical company that develops, manufactures, and markets a broad range of medicines and healthcare products for patients and healthcare providers worldwide. Its current business centers on pharmaceuticals and new ventures, with a portfolio that includes generic medicines, active pharmaceutical ingredients, biosimilars, and consumer health products across therapeutic areas such as respiratory care, cardiovascular disease, infectious diseases, metabolic disorders, oncology, dermatology, and central nervous system conditions. The company also supports access-to-medicine initiatives through its global access business, supplying essential treatments in low- and middle-income markets. Cipla Ltd. plays an important role in the pharmaceutical market through its focus on off-patent medicines, complex generics, and large-scale manufacturing capabilities across multiple sites.